Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02142426
Other study ID # 56-RW-021
Secondary ID
Status Completed
Phase N/A
First received September 13, 2011
Last updated November 24, 2015
Start date August 2011
Est. completion date June 2012

Study information

Verified date November 2015
Source Southwest Regional Wound Care Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study was to pursue statistical analysis on a series of molecular laboratory results obtained from chronic wounds. It elucidated diversity, quantification, and other aspects of microbial diversity in chronic wounds.


Description:

The information was processed from culture results that were processed to compile an antibiogram for a laboratory.


Recruitment information / eligibility

Status Completed
Enrollment 2000
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

-Patients with chronic wounds.

Exclusion Criteria:

-Patients without chronic wounds.

Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Southwest Regional Wound Care Center Lubbock Texas

Sponsors (1)

Lead Sponsor Collaborator
Southwest Regional Wound Care Center

Country where clinical trial is conducted

United States, 

References & Publications (1)

Dowd SE, Wolcott RD, Kennedy J, Jones C, Cox SB. Molecular diagnostics and personalised medicine in wound care: assessment of outcomes. J Wound Care. 2011 May;20(5):232, 234-9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Improve selection of systemic antibiotics based on results using molecular diagnostics. The study elucidated diversity, quantification, and other aspects of microbial diversity in chronic wounds. It evaluated samples from different regions, different types of wounds, different outcomes, and longitudinal data if multiple samples were sent over time from a single individual. 1 year No
Secondary 2. Data Collection: The molecular wound cultures have been performed on thousands of patients from around the country. The information from the culture results that were processed were used to compile an antibiogram for a laboratory. There are many geographic regions which have a number of samples which could be analyzed and compared to other geographic regions yielding valuable insight into the microbiology of chronic wounds. 1 year No
See also
  Status Clinical Trial Phase
Completed NCT02138994 - Next Science Wound Gel Efficacy in Chronic Wound Versus Standard of Care N/A